Search filters

List of works by Peter Attia

Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade

scientific article

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

scientific article

Closed-loop optimization of fast-charging protocols for batteries with machine learning

scientific article published on 19 February 2020

Correction to "Evolution of the Solid-Electrolyte Interphase on Carbonaceous Anodes Visualized by Atomic-Resolution Cryogenic Electron Microscopy"

scientific article published on 12 June 2020

Enhanced room temperature electronic and thermoelectric properties of the dilute bismuthide InGaBiAs

Evolution of the Solid-Electrolyte Interphase on Carbonaceous Anodes Visualized by Atomic-Resolution Cryogenic Electron Microscopy

scientific article published on 23 July 2019

Fluid-enhanced surface diffusion controls intraparticle phase transformations

article

Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma

scientific article

Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma

scientific article

Mega-Sized Concerns from the Nano-Sized World: The Intersection of Nano- and Environmental Ethics

scientific article published on December 6, 2012

Outlive

book by Peter Attia

Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and review

scientific article

Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration

scientific article

Peter Attia: Is the obesity crisis hiding a bigger problem?

2013 video of a TEDMED 2013 talk

Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2.

scientific article

Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study

scientific article